Strategic Approaches To Controlled Release Formulation: Polymer Screening And Case Study Insights

Controlled release (CR) formulations represent a key strategy in pharmaceutical product design, offering the ability to optimize pharmacokinetic (PK) profiles, improve therapeutic outcomes, and enhance patient adherence by reducing dosing frequency. Among the many CR technologies — such as polymer coatings, matrix systems, osmotic pumps, microencapsulation, and gastro-retentive platforms — the monolithic matrix tablet remains a straightforward yet highly effective option for initiating extended-release development in appropriate drug candidates.

This webinar will highlight practical strategies for CR formulation, with an emphasis on a streamlined screening approach to identify polymers with the greatest potential to achieve desired release profiles. Participants will learn how early-stage polymer selection can shape formulation design and performance. Case studies will demonstrate the direct link between polymer choice and drug release behavior, equipping formulation scientists with actionable insights to advance the development of robust CR products.